why choose us

300×250 Ad Slot

Research Article: Hexokinase2-engineered T cells display increased anti-tumor function

Date Published: 2025-03-20

Abstract:
Background: T cells face significant metabolic challenges in the tumor microenvironment (TME), where cancer cells monopolize critical nutrients like glucose and amino acids. This metabolic competition supports tumor growth while impairing T-cell anti-tumor responses, partly by reducing glycolytic function. Hexokinase 2 (HK2), a key enzyme in glycolysis, plays a pivotal role in maintaining T-cell functionality.

No summary available.

300×250 Ad Slot